How Zollinger-Ellison Syndrome Medications Work

Zollinger-Ellison Syndrome is a rare disorder characterized by excessive gastrin production, leading to severe peptic ulcers and other gastrointestinal symptoms. The primary goal of medication therapy in this condition is to reduce gastric acid secretion and alleviate symptoms.

Medication Classes for Zollinger-Ellison Syndrome

• Somatostatin analogs (Octreotide, Lanreotide): These medications mimic the action of somatostatin, a natural hormone that inhibits gastrin release. They are effective in reducing gastric acid secretion and symptoms.
• Proton pump inhibitors (PPIs) (Omeprazole, Lansoprazole): PPIs block the final step of acid production in the stomach, providing rapid and sustained reduction in gastric acidity.
• Histamine-2 receptor antagonists (H2RAs) (Famotidine, Ranitidine): H2RAs reduce histamine-stimulated acid secretion, but are generally less effective than PPIs or somatostatin analogs in Zollinger-Ellison Syndrome.

Medication Selection and Monitoring

The choice of medication depends on the severity of symptoms, patient tolerance, and potential side effects. Regular monitoring of gastrin levels, gastric acid secretion, and symptom control is essential to adjust therapy as needed. In some cases, surgery may be considered for patients with refractory disease or those who are resistant to medical therapy.